Cancer Genetics IPO Research Information

Cancer Genetics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Cancer Genetics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Cancer Genetics	CGIX - NASDAQ	$10.00-$12.00	$10.00	$10.00	600 Thousand	4/5/2013
Underwriter(s): Aegis Capital Corp, Feltl & Co.
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2011-12-30

Cancer Genetics Quote & Chart - Click for current quote - CGIX

About Cancer Genetics (adapted from Cancer Genetics prospectus):
They are a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment (theranosis) of cancer.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "CGIX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.